Moreover, while no significant differences were detected in MEK5 protein steady-state levels, 5-FU treatment negatively modulated the levels of endogenous MEK5 activation in both colon cancer cell models (p < 0.01 in HCT116 cells) (Figure 2A and 2B, middle panel). This evidence concerns the gene MAP2K5 and colonic neoplasm.